MELONI, MARIO
 Distribuzione geografica
Continente #
EU - Europa 65.110
NA - Nord America 2.139
AS - Asia 1.098
SA - Sud America 146
Continente sconosciuto - Info sul continente non disponibili 96
AF - Africa 44
OC - Oceania 26
Totale 68.659
Nazione #
IT - Italia 64.471
US - Stati Uniti d'America 2.071
SG - Singapore 399
CN - Cina 317
SE - Svezia 156
BR - Brasile 116
GB - Regno Unito 101
VN - Vietnam 96
DE - Germania 87
FR - Francia 60
FI - Finlandia 46
CA - Canada 44
IN - India 43
KR - Corea 41
UA - Ucraina 39
HK - Hong Kong 36
NL - Olanda 27
AU - Australia 22
ES - Italia 22
TW - Taiwan 22
TR - Turchia 19
IQ - Iraq 17
IR - Iran 16
JP - Giappone 16
RO - Romania 14
ZA - Sudafrica 14
AT - Austria 13
PH - Filippine 13
IE - Irlanda 12
MX - Messico 12
MY - Malesia 10
RU - Federazione Russa 10
AR - Argentina 9
CZ - Repubblica Ceca 8
EG - Egitto 8
PL - Polonia 8
SA - Arabia Saudita 8
VE - Venezuela 7
CH - Svizzera 6
IL - Israele 6
KE - Kenya 6
BD - Bangladesh 5
BE - Belgio 5
MA - Marocco 5
TH - Thailandia 5
ET - Etiopia 4
LB - Libano 4
NZ - Nuova Zelanda 4
PK - Pakistan 4
PT - Portogallo 4
RS - Serbia 4
TN - Tunisia 4
UZ - Uzbekistan 4
AL - Albania 3
GR - Grecia 3
ID - Indonesia 3
JM - Giamaica 3
LV - Lettonia 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
BG - Bulgaria 2
CL - Cile 2
CO - Colombia 2
EC - Ecuador 2
JO - Giordania 2
MT - Malta 2
NP - Nepal 2
PE - Perù 2
UY - Uruguay 2
AM - Armenia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EU - Europa 1
GD - Grenada 1
GP - Guadalupe 1
HN - Honduras 1
HR - Croazia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
PA - Panama 1
PS - Palestinian Territory 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TT - Trinidad e Tobago 1
Totale 68.564
Città #
Cagliari 63.327
Uta 876
Singapore 227
Ashburn 208
Chandler 158
San Jose 122
Fairfield 117
Nyköping 97
Boardman 85
Dallas 85
Beijing 73
New York 65
Woodbridge 60
Houston 57
Shanghai 54
Augusta 52
Seattle 52
Wilmington 49
Ann Arbor 48
Los Angeles 48
Santa Clara 39
Cambridge 37
Helsinki 37
Seoul 37
Dearborn 36
Ho Chi Minh City 31
Redwood City 30
The Dalles 28
Hong Kong 27
Hanoi 24
Lauterbourg 22
Jacksonville 20
Council Bluffs 19
Boston 17
Frankfurt am Main 17
São Paulo 17
Buffalo 16
London 16
Atlanta 15
Orem 14
Munich 13
Denver 12
Dublin 12
Stockholm 12
Amsterdam 11
Baghdad 11
Finale Ligure 11
Hefei 11
Phoenix 11
Chennai 10
Glasgow 10
Guangzhou 10
Manchester 10
Chicago 9
San Mateo 9
Syracuse 9
Tokyo 9
Brooklyn 8
Milan 8
Montreal 8
Rome 8
Tramatza 8
Vienna 8
Changsha 7
Curitiba 7
Dolianova 7
Nanjing 7
Nottingham 7
Taipei 7
Bacolod City 6
Cairo 6
Central 6
Düsseldorf 6
Falls Church 6
Istanbul 6
Johannesburg 6
Mumbai 6
Nuremberg 6
Paris 6
Rio de Janeiro 6
San Diego 6
San Francisco 6
Sydney 6
Toronto 6
Bangkok 5
Brno 5
Bucharest 5
Cape Town 5
Haiphong 5
Melbourne 5
Perham 5
Richmond 5
Shenyang 5
Auburn 4
Cagayan de Oro 4
Da Nang 4
Edgemont 4
Falkenstein 4
Galatina 4
Jena 4
Totale 66.792
Nome #
Efficacy and safety of the 5-Hydroxytryptophan on Levodopa-Induced Motor Complications in Parkinson's disease 24.356
C9ORF72 intermediate repeat expansion in patients affected by atypical Parkinsonian syndromes or parkinson’s disease complicated by psychosis or dementia in a Sardinian population 4.290
The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease 4.085
Efficacy and safety of the 5-Hydroxytryptophan on Depression and Apathy in Parkinson's disease: a preliminary finding 3.346
Pisa-Like Syndrome Under Baclofen in a Patient With Spastic Hemiparesis due to Ischemic Stroke 3.184
Focal 123I-FP-CIT SPECT abnormality in a patient with midbrain vascular Parkinsonism 3.103
Efficacy and safety of 5-Hydroxytryptophan on levodopa-induced motor complications in Parkinson's disease: A preliminary finding 2.370
Efficacy and Safety of the 5-Hydroxytryptophan on REM Sleep Behavior Disorder in Parkinson's Disease 2.269
Severity of REM sleep without atonia (RSWA) correlates with cognitive functions in patients with REM sleep behaviour disorder (RBD) 2.203
Efficacy and safety of the 5-Hydroxytryptophan on Depression and Apathy in Idiopathic Parkinson's disease 2.167
Neuropsychological and behavioral profile of patients with isolated REM sleep behaviour disorders (iRBD) and patients with RBD associated with Parkinson's Disease (PDRBD) 2.129
Association between dopaminergic medications and REM sleep behavior disorder in Parkinson’s disease: a preliminary cohort study 1.761
Does REM sleep behavior disorder change in the progression of Parkinson’s disease? 1.705
Diagnosing REM sleep behavior disorder in Parkinson's disease without a gold standard: a latent-class model study 1.523
A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Safety and Efficacy of the 5-Hydroxytryptophan on REM Sleep Behavior Disorder, Levodopa-Induced Motor Complications and Neuropsychiatric Disorders in Idiopathic Parkinson's disease. 1.489
DIAGNOSING REM SLEEP BEHAVIOUR DISORDER IN PARKINSON DISEASE WITHOUT A GOLD STANDARD: A LATENT CLASSES MODELS STUDY 1.374
Does REM Sleep Behavior Disorder Change in the Progression of Parkinson’s Disease? 1.361
REM sleep behavior disorder changes in the progression of Parkinson's disease: a longitudinal study 1.343
Cognitive and Behavioral features of isolated Rem Sleep Bhaviour disorders (IRBD) and RBD associated with Parkinson's disease (PDRBD 1.050
Preliminary finding of a randomized, double-blind, placebo-controlled, crossover study to evaluate the safety and efficacy of 5-hydroxytryptophan on REM sleep behavior disorder in Parkinson's disease 989
Neurophysiological features of REM sleep Behaviour Disorder (RBD) correlate with cognitive and psycho-behavioral profile 966
Severity of REM sleep without atonia correlates with measures of cognitive impairment and depressive symptoms in REM sleep behaviour disorder 582
Considering REM Sleep Behavior Disorder in the Management of Parkinson's Disease 525
Oligomeric Alpha-Synuclein and STX-1A from Neural-Derived Extracellular Vesicles (NDEVs) as Possible Biomarkers of REM Sleep Behavior Disorder in Parkinson's Disease: A Preliminary Cohort Study 417
Oligomeric α-synuclein and tau aggregates in NDEVs differentiate Parkinson's disease from atypical parkinsonisms 72
Totale 68.659
Categoria #
all - tutte 80.589
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.589


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.584 0 229 186 143 214 288 281 126 181 297 269 370
2022/20233.611 366 509 495 325 317 280 171 214 215 218 348 153
2023/20243.703 119 129 140 250 356 519 551 253 146 240 460 540
2024/202528.284 12.124 4.952 9.001 692 375 367 409 61 95 63 71 74
2025/20261.803 201 73 157 178 152 164 333 105 153 179 68 40
2026/2027182 44 138 0 0 0 0 0 0 0 0 0 0
Totale 68.659